{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:36:42Z","timestamp":1764333402191,"version":"3.41.2"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>This study aimed to investigate the efficacy of using a newly formulated magnesium-rich artificial cerebrospinal fluid (MACSF) as an alternative to normal saline (NS) for intraoperative irrigation during aneurysm clipping in improving the prognosis of patients with Aneurysmal subarachnoid hemorrhage (aSAH).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients with aSAH who underwent intraoperative irrigation with MACSF or NS during the clipping in the First Affiliated Hospital of Xi \u2018an Jiaotong University from March 2019 to March 2022 were selected as MACSF group and NS group, respectively. The primary prognostic indicators were the incidence of favorable outcomes (mRS 0\u20132). The secondary outcome measures included cerebral vasospasm (CVS), mortality, total hospital stay, and intensive care unit (ICU) stay. Safety was evaluated based on the occurrence rates of hypermagnesemia, meningitis, and hydrocephalus.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Overall, 34 and 37 patients were enrolled in the MACSF and NS groups, respectively. At 90\u2009days after aSAH onset, the proportion of favorable prognosis in the MACSF group was significantly higher than that in the NS group (<jats:italic>p<\/jats:italic>\u2009=\u20090.035). The incidence of CVS within 14\u2009days after surgery was significantly lower in the MACSF group than that in the NS group (<jats:italic>p<\/jats:italic>\u2009=\u20090.026). The mortality rate in the MACSF group was significantly lower than in the NS group (<jats:italic>p<\/jats:italic>\u2009=\u20090.048). The median lengths of hospital stay (<jats:italic>p<\/jats:italic>\u2009=\u20090.008) and ICU stay (<jats:italic>p<\/jats:italic>\u2009=\u20090.018) were significantly shorter in the MACSF group than in the NS group. No significant differences were observed in safety measures.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Using MACSF as an irrigation fluid for aneurysm clipping can significantly improve the 90-day prognosis of patients with aSAH, which may be related to the reduced incidence of CVS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical trial registration<\/jats:title><jats:p><jats:ext-link>https:\/\/www.clinicaltrials.gov<\/jats:ext-link>, identifier NCT04358445.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2024.1376216","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T04:27:25Z","timestamp":1711600045000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Safety and efficacy of magnesium-rich artificial cerebrospinal fluid for subarachnoid hemorrhage"],"prefix":"10.3389","volume":"15","author":[{"given":"Yawen","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangning","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanfu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaofeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobin","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linjuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihua","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiyi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengsen","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fude","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangqi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guogang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0967-5868(94)90005-1","article-title":"A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage part I: incidence and effects","volume":"1","author":"Dorsch","year":"1994","journal-title":"J Clin Neurosci"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10143-015-0617-3","article-title":"Diagnosis of cerebral vasospasm and risk of delayed cerebral ischemia related to aneurysmal subarachnoid haemorrhage: an overview of available tools","volume":"38","author":"Bacigaluppi","year":"2015","journal-title":"Neurosurg Rev"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.ijsu.2010.07.292","article-title":"Possible detrimental effects of neurosurgical irrigation fluids on neural tissue: an evidence based analysis of various irrigants used in contemporary neurosurgical practice","volume":"8","author":"Kazim","year":"2010","journal-title":"Int J Surg"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3171\/jns.1949.6.2.0140","article-title":"Physiological salt solutions for brain surgery\u2014stuides of local PH and pial vessel reactions to buffered and unbuffered isotonic solutions","volume":"6","author":"Elliott","year":"1949","journal-title":"J Neurosurg"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1248\/bpb.34.688","article-title":"Intrathecal disposition of ARTCEREB (R) irrigation and perfusion solution for cerebrospinal surgery in rats","volume":"34","author":"Morioka","year":"2011","journal-title":"Biol Pharm Bull"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.surneu.2003.12.014","article-title":"Possible harmful effects on central nervous system cells in the use of physiological saline as an irrigant during neurosurgical procedures","volume":"62","author":"Milhorat","year":"2004","journal-title":"Surg Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/00008506-200604000-00009","article-title":"Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: a prospective randomized pilot study","volume":"18","author":"Wong","year":"2006","journal-title":"J Neurosurg Anesthesiol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S0140-6736(12)60724-7","article-title":"Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomized placebo-controlled trial","volume":"380","author":"Dorhout Mees","year":"2012","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1136\/bmj.3.5561.356","article-title":"Davson H-physiology of cerebrospinal fliud","volume":"3","author":"Walton","year":"1967","journal-title":"Br Med J"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1080\/01616412.2019.1672383","article-title":"Effects of a new magnesium-rich artificial cerebrospinal fluid on contractile 5-hydroxytryptamine and endothelin receptors in rat cerebral arteries","volume":"41","author":"Cheng","year":"2019","journal-title":"Neurol Res"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1136\/bmj.e7586","article-title":"Explanation and elaboration: guidance for protocols of clinical trials","volume":"2013","author":"Chan","year":"2013","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","article-title":"Interobserver agreement for the assessment of handicap in stroke patients","volume":"19","author":"van Swieten","year":"1988","journal-title":"Stroke"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1747-4949.2009.00271.x","article-title":"Functional outcome measures in contemporary stroke trials","volume":"4","author":"Quinn","year":"2009","journal-title":"Int J Stroke"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1227\/NEU.0b013e31826a8a56","article-title":"Simple and reliable determination of the modified Rankin scale score in neurosurgical and neurological patients: the mRS-9Q","volume":"71","author":"Patel","year":"2012","journal-title":"Neurosurgery"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1411587","article-title":"A randomized trial of intraarterial treatment for acute ischemic stroke","volume":"372","author":"Berkhemer","year":"2015","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1056\/NEJMoa1213701","article-title":"Endovascular treatment for acute ischemic stroke","volume":"368","author":"Ciccone","year":"2013","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1161\/hs1001.097108","article-title":"Transcranial Doppler versus angiography in patients with vasospasm due to a ruptured cerebral aneurysm\u2014a systematic review","volume":"32","author":"Lysakowski","year":"2001","journal-title":"Stroke"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1097\/00003246-200206000-00035","article-title":"Symptomatic vasospasm diagnosis after subarachnoid hemorrhage: evaluation of transcranial Doppler ultrasound and cerebral angiography as related to compromised vascular distribution","volume":"30","author":"Suarez","year":"2002","journal-title":"Crit Care Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.26355\/eurrev_201804_14732","article-title":"Clinical diagnosis of cerebral vasospasm after subarachnoid hemorrhage by using transcranial Doppler sonography","volume":"22","author":"Li","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/BF01405268","article-title":"Cerebral vasospasm diagnosis by means of angiography and blood velocity measurements","volume":"100","author":"Lindegaard","year":"1989","journal-title":"Acta Neurochir"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11910-009-0008-7","article-title":"Advances in transcranial doppler ultrasonography","volume":"9","author":"Tsivgoulis","year":"2009","journal-title":"Curr Neurol Neurosci Rep"},{"volume-title":"14th International Conference on Neurvascular Events after Subarachnoid Hemorrage (Vasospasm)","year":"2017","key":"ref22"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fneur.2014.00052","article-title":"Magnesium: potential roles in neurovascular disease","volume":"5","author":"Chang","year":"2014","journal-title":"Front Neurol"},{"key":"ref24","first-page":"289","article-title":"Pharmacological interactions between magnesium ion and adenosine on monoaminergic system in the central nervous system","volume":"11","author":"Okada","year":"1998","journal-title":"Magnes Res"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1046\/j.1471-4159.1998.70010077.x","article-title":"The effect of magnesium on oxidative neuronal injury in vitro","volume":"70","author":"Regan","year":"1998","journal-title":"J Neurochem"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neures.2015.12.005","article-title":"Mechanisms of magnesium-induced vasodilation in cerebral penetrating arterioles","volume":"107","author":"Murata","year":"2016","journal-title":"Neurosci Res"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1179\/016164106X115035","article-title":"Magnesium therapy within 48 hours of an aneurysmal subarachnoid hemorrhage: neuro-panacea","volume":"28","author":"Wong","year":"2006","journal-title":"Neurol Res"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.3171\/2010.10.JNS10866","article-title":"Optimal cerebrospinal fluid magnesium ion concentration for vasodilatory effect and duration after intracisternal injection of magnesium sulfate solution in a canine subarachnoid hemorrhage model","volume":"114","author":"Mori","year":"2011","journal-title":"J Neurosurg"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"596","DOI":"10.2176\/nmc.oa2012-0295","article-title":"Potential risk of artificial cerebrospinal fluid solution without magnesium ion for cerebral irrigation and perfusion in neurosurgical practice","volume":"53","author":"MORI","year":"2013","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3171\/2015.1.JNS142757","article-title":"Preventive effect of continuous cisternal irrigation with magnesium sulfate solution on angiographic cerebral vasospasms associated with aneurysmal subarachnoid hemorrhages: a randomized controlled trial","volume":"124","author":"Yamamoto","year":"2016","journal-title":"J Neurosurg"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1161\/STROKEAHA.120.031260","article-title":"Intravenous hydrogen therapy with intracisternal magnesium sulfate infusion in severe aneurysmal subarachnoid hemorrhage","volume":"52","author":"Takeuchi","year":"2021","journal-title":"Stroke"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1376216\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T04:28:18Z","timestamp":1711600098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1376216\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,28]]},"references-count":31,"alternative-id":["10.3389\/fneur.2024.1376216"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1376216","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2024,3,28]]},"article-number":"1376216"}}